Journal of Clinical Endocrinology & Metabolism, Vol 51, 179-181, Copyright © 1980 by Endocrine Society

ARTICLES

The role of endogenous opiates in LH secretion during the menstrual cycle

ME Quigley and SS Yen

To determine whether endogenous opiates exert an inhibitory action on LH secretion during the menstrual cycle, LH increments were examined in response to a specific opiate antagonist, naloxone, infused at 1.6 mg/hr for 4 hrs. Naloxone had no discernible effect on LH release during the early follicular phase. By contrast, a significant LH increment was observed in both the late follicular and mid-luteal phases of the cycle but the patterns of LH increment were distinct. Late follicular subjects exhibited slow, progressive increases in LH, while prompt, episodic and quantitatively greater LH increments were evident in mid-luteal phase subjects. These observations suggest that endogenous opiates are involved in the regulation of LH secretion during the high estrogen and estrogen-progesterone phases of the menstrual cycle.

This article has been cited by other articles:

				J. A. Taylor, M.-L. Goubillon, K. D. Broad, and J. E. Robinson Steroid Control of Gonadotropin-Releasing Hormone Secretion: Associated Changes in Pro-Opiomelanocortin and Preproenkephalin Messenger RNA Expression in the Ovine Hypothalamus Biol Reprod, March 1, 2007; 76(3): 524 - 531. [Abstract] [Full Text] [PDF]

				A. D. GENAZZANI, F. RICCHIERI, C. LANZONI, C. STRUCCHI, and V. M. JASONNI Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 103 - 113. [Abstract] [Full Text] [PDF]

				S.K. Blank, C.R. McCartney, and J.C. Marshall The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361. [Abstract] [Full Text] [PDF]

				R. L. Goodman, L. M. Coolen, G. M. Anderson, S. L. Hardy, M. Valent, J. M. Connors, M. E. Fitzgerald, and M. N. Lehman Evidence That Dynorphin Plays a Major Role in Mediating Progesterone Negative Feedback on Gonadotropin-Releasing Hormone Neurons in Sheep Endocrinology, June 1, 2004; 145(6): 2959 - 2967. [Abstract] [Full Text] [PDF]

				C. D. Foradori, L. M. Coolen, M. E. Fitzgerald, D. C. Skinner, R. L. Goodman, and M. N. Lehman Colocalization of Progesterone Receptors in Parvicellular Dynorphin Neurons of the Ovine Preoptic Area and Hypothalamus Endocrinology, November 1, 2002; 143(11): 4366 - 4374. [Abstract] [Full Text] [PDF]

				A. P. Cemeroglu, G. B. Kletter, W. Guo, M. B. Brown, R. P. Kelch, J. C. Marshall, V. Padmanabhan, and C. M. Foster In Pubertal Girls, Naloxone Fails to Reverse the Suppression of Luteinizing Hormone Secretion by Estradiol J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3501 - 3506. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 736 - 743. [Abstract] [Full Text]

				A. Arroyo, G. A. Laughlin, A. J. Morales, and S. S. C. Yen Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3728 - 3733. [Abstract] [Full Text] [PDF]

				A. J. Rapkin, D. Shoupe, A. Reading, K. K. Daneshgar, L. Goldman, Y. Bohn, D. W. Brann, and V. B. Mahesh Decreased Central Opioid Activity in Premenstrual Syndrome: Luterinizing Hormone Response to Naloxone Reproductive Sciences, March 1, 1996; 3(2): 93 - 98. [Abstract] [PDF]